Related Experiment Video
Updated: Oct 2, 2026

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques
Published on: June 1, 2016
Ultrastructural evidence of microglial heterogeneity in Alzheimer's disease amyloid pathology
Hassan El Hajj1, Julie C Savage1, Kanchan Bisht1
1Axe neurosciences, Centre de recherche du CHU de Québec-Université Laval, 2705, boulevard Laurier, T2-50, Quebec, QC, G1V 4G2, Canada.
Background:
Alzheimer's disease (AD) is the most common neurodegenerative disease, characterized by the deposition of extracellular fibrillar amyloid β (fΑβ) and the intracellular accumulation of neurofibrillary tangles. As AD progresses, Aβ drives a robust and prolonged inflammatory response via its recognition by microglia, the brain's immune cells. Microglial reactivity to fAβ plaques may impair their normal surveillance duties, facilitating synaptic loss and neuronal death, as well as cognitive decline in AD.
Methods:
In the current study, we performed correlative light, transmission, and scanning electron microscopy to provide insights into microglial structural and functional heterogeneity. We analyzed microglial cell bodies and processes in areas containing fAβ plaques and neuronal dystrophy, dystrophy only, or appearing healthy, among the hippocampus CA1 of 14-month-old APPSwe-PS1Δe9 mice versus wild-type littermates.
Results:
Our quantitative analysis revealed that microglial cell bodies in the AD model mice were larger and displayed ultrastructural signs of cellular stress, especially nearby plaques. Microglial cell bodies and processes were overall less phagocytic in AD model mice. However, they contained increased fibrillar materials and non-empty inclusions proximal to plaques. Microglial cell bodies and processes in AD model mice also displayed reduced association with extracellular space pockets that contained debris. In addition, microglial processes in healthy subregions of AD model mice encircled synaptic elements more often compared with plaque-associated processes. These observations in mice were qualitatively replicated in post-mortem hippocampal samples from two patients with AD (Braak stage 5).
Conclusion:
Together, our findings identify at the ultrastructural level distinct microglial transformations common to mouse and human in association with amyloid pathology.
Insights
Alzheimer's disease (AD) alters microglia, the brain's immune cells, causing them to become larger, stressed, and less effective at clearing amyloid beta plaques. These changes are observed in both mouse models and human AD brains.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Alzheimer's disease (AD) is a common neurodegenerative disorder.
- AD is characterized by amyloid-beta (Aβ) plaques and neurofibrillary tangles.
- Microglia, the brain's immune cells, become reactive to Aβ, potentially impairing cognitive function.
Purpose of the Study:
- To investigate microglial structural and functional heterogeneity in Alzheimer's disease.
- To compare microglia in AD model mice with those in healthy controls.
- To examine microglial changes in relation to amyloid pathology and neuronal health.
Main Methods:
- Correlative light, transmission, and scanning electron microscopy were employed.
- Microglia were analyzed in the hippocampus of APP-PS1Δe9 mice and wild-type littermates.
- Human post-mortem hippocampal samples from AD patients were also examined.
Main Results:
- Microglial cell bodies were larger and showed signs of stress in AD model mice, particularly near plaques.
- Microglia in AD models were less phagocytic but contained more fibrillar material and inclusions.
- Microglial processes in healthy brain regions of AD mice more frequently associated with synapses than those near plaques.
- Similar microglial changes were observed in human AD brain samples.
Conclusions:
- Distinct microglial ultrastructural transformations occur in association with amyloid pathology.
- These microglial changes are conserved between AD mouse models and human patients.
- Understanding these microglial alterations is crucial for developing AD therapies.
More Related Videos
09:33Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019